N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid is a protected, amino acid-derived building block in which the α-amino group is Boc-protected and the backbone bears an additional β-substituent that includes a 4,4-dimethyl-2,6-dioxocyclohex-1-ylidene (cyclohexanedione-derived) functionality. The molecule contains an α-carboxylic acid and an L-2,3-diaminopropionic acid framework with two amino groups overall, and the Boc group and the cyclic ketone-derived substituent modulate chemoselectivity and reactivity by reducing free amine participation while introducing carbonyl-bearing structural features. In peptide and amino acid derivative synthesis, it functions as a protected intermediate that can be used to incorporate the substituted diamino acid motif into larger constructs while providing controlled handling of the amine functionality and a defined side-chain-like carbonyl-containing substituent for subsequent chemical elaboration or analytical characterization.
CAT No: CP05817
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid is a protected L-2,3-diaminopropionic acid derivative in which the α-amino group is Boc-protected and the β-amino functionality is incorporated into a chiral, substituted framework. The molecule contains a carboxylic acid for peptide coupling, a Boc carbamate that modulates amine reactivity during synthesis, and a ring-derived 1-ylidene substituent bearing two carbonyl groups that can act as a rigidifying, electrophile-adjacent motif for subsequent functional transformations. The presence of two stereochemically relevant amino-bearing centers enables stereocontrolled incorporation into peptide-like scaffolds and supports downstream derivatization at the diamino backbone. The combination of protected amine chemistry, acid functionality, and a carbonyl-rich cyclic substituent makes this compound a practical intermediate for constructing constrained amino acid analogs and for preparing defined chiral building blocks used in synthetic peptide chemistry and structure-driven molecular design.
1. Peptide Synthesis
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid serves as a peptide building block in protected-amino-acid synthesis where the carboxylic acid can be activated for amide bond formation. The Boc-protected α-amine helps control selectivity during coupling by suppressing undesired side reactions, while the remaining amino functionality supports defined branching or further orthogonal protection strategies. The rigid, carbonyl-containing cyclohexylidene substituent can influence conformational preferences in the resulting peptide analogs, enabling controlled placement of functional groups along the backbone. Downstream, the compound can be used to generate constrained peptide fragments for library construction, peptide mimetics, and mechanistic studies of backbone recognition.
2. Protected Amino Acid Chemistry
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid functions as a chiral, N-protected amino acid intermediate for stepwise protection and deprotection planning in multi-amino systems. The Boc carbamate provides a predictable handle for orthogonal deprotection relative to other protecting groups that may be installed on the diamino backbone. The carboxylic acid enables conversion into activated derivatives used in amino acid ester synthesis and peptide coupling workflows, while the carbonyl-rich 1-ylidene substituent can participate in subsequent derivatization sequences that require controlled chemoselectivity. Defined stereochemistry at the L-2,3-diaminopropionic acid core supports reproducible formation of stereochemically consistent intermediates for fine chemical synthesis and peptide analog preparation.
3. Peptidomimetics And SAR
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid is suitable for peptidomimetic construction in structure-activity relationship studies where constrained geometry and functional group placement affect molecular recognition. The diamino backbone enables incorporation into analogs that mimic turn-forming or binding-interface motifs, while the Boc-protected amine supports selective elaboration during scaffold assembly. The 4,4-dimethyl-2,6-dioxocyclohex-1-ylidene group introduces a rigid, carbonyl-bearing element that can modulate local polarity and hydrogen-bonding patterns in the final analog. Resulting derivatives can be used to generate SAR-focused series of amino acid analogs and backbone-modified fragments for screening-compatible chemistry and iterative design.
4. Chemical Biology Labeling
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid can be applied in chemical biology workflows that require defined amino acid incorporation into labeled peptides or biomolecule probes. The presence of a protected amine and a carboxylic acid supports controlled conjugation strategies, including preparation of peptide conjugates that later undergo selective deprotection to expose reactive amines for coupling to targeting groups. The carbonyl-rich cyclic substituent provides a handle for downstream functionalization routes that can introduce linkers or reactive intermediates while maintaining the stereochemical integrity of the L-amino acid core. Labeled constructs derived from this intermediate can serve as defined standards for studying binding interactions, processing of peptide-like substrates, or mapping of recognition elements in protein systems.
5. Pharmaceutical Manufacturing Intermediates
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid is relevant to pharmaceutical manufacturing chemistry as a chiral intermediate for producing protected amino acid building blocks used in peptide-based active ingredient synthesis. The Boc-protected α-amine and carboxylic acid allow integration into controlled coupling sequences that minimize side reactions in multi-step assembly of peptide fragments. The rigid, carbonyl-containing substituent can support reproducible formation of well-defined analogs that are incorporated into drug-like peptide scaffolds, where stereochemical consistency and functional group stability are critical for downstream processing. This intermediate can also serve in process chemistry for manufacturing route design that leverages orthogonal protection logic and chemoselective transformations to access defined stereochemical variants.
6. Analytical Standards and Method Development
N-α-Boc-N-β-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid can be employed as a reference material in analytical research for method development involving amino acid derivatives and peptide-like intermediates. The combination of Boc carbamate, carboxylic acid, and carbonyl-rich cyclic substituent yields a distinctive set of chromatographic and spectroscopic signatures that can support identification and monitoring of protected amino acid synthesis steps. The defined L-stereochemistry and diamino pattern enable use in calibration strategies for quantifying protected intermediate formation or conversion during peptide building block preparation. Downstream, this compound-derived material can support analytical characterization of peptide coupling products, impurity profiling, and structural verification in amino acid derivative workflows.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.